Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rozemarie Gilles"'
Autor:
Mireille Cantarini, Wim J.G. Oyen, Rozemarie Gilles, Ingrid M.E. Desar, Carla M.L. van Herpen, Winette T. A. van der Graaf, Anja J N H Timmer-Bonte
Publikováno v:
World Journal of Nuclear Medicine
Selumetinib (AZD6244, ARRY-142886) is a potent, selective, uncompetitive inhibitor of MEK 1 / 2, part of the RAF/MEK/ERK protein kinase signal cascade, which is responsible for tumor. This pilot study was used to explore if 18 F-fluoro-l-thymidine (F
Autor:
Geert O. Janssens, Corrie Gidding, Ton M. van der Vliet, Wim J.G. Oyen, Rozemarie Gilles, Wouter V. Vogel
Publikováno v:
Nuclear Medicine Communications, 31, 6, pp. 482-487
Nuclear Medicine Communications, 31, 482-7
Nuclear Medicine Communications, 31, 6, pp. 482-7
Nuclear Medicine Communications, 31, 482-487
Nuclear Medicine Communications, 31, 482-7
Nuclear Medicine Communications, 31, 6, pp. 482-7
Nuclear Medicine Communications, 31, 482-487
Contains fulltext : 89777.pdf (Publisher’s version ) (Closed access) BACKGROUND: F-fluoro-L-thymidine (FLT) has been shown to be a useful PET tracer in the evaluation of brain tumours in adults. No studies of this modality in children with brain tu
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 4 (2003)
Introduction This study investigated the central haemodynamic, blood pressure (BP) and pulse wave responses to progressively increasing infusion rates of intravenous angiotensin II (Ang II) in normal volunteers during chronic therapy with telmisartan
Publikováno v:
Blood pressure. 13(2)
The functional existence of angiotensin type 2 (AT2) receptors in healthy humans is uncertain. A double-blind, randomized, crossover study was performed comparing forearm vascular responses to intrabrachial arterial PD123319 (a selective AT2 receptor
Autor:
W.T.A. van der Graaf, C.M.L. van Herpen, Mireille Cantarini, Ingrid M.E. Desar, Rozemarie Gilles, Wim J.G. Oyen, Anja J N H Timmer-Bonte
Publikováno v:
European Journal of Cancer Supplements. 6:113
Publikováno v:
World Journal of Urology, 31, 4, pp. 841-6
World Journal of Urology
World Journal of Urology, 31, 841-6
World Journal of Urology
World Journal of Urology, 31, 841-6
Item does not contain fulltext BACKGROUND: CT imaging is widely used for response evaluation of immunotherapy in patients with advanced stage renal cell carcinoma (RCC). However, this kind of treatment may not immediately be cytoreductive, although t